Abbreviations
Reports - EMCDDA Report on the risk assessment of PMMA |
Drug Abuse
BKA Bundeskriminalamt
CAM Coordination Centre for Assessment and Monitoring of New Drugs of Misuse
DEA Drugs Enforcement Administration
Europol European Police Office
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
EMEA European Agency for the Evaluation of Medicinal Products
Reitox European information network on drugs and drug addiction
3,4 DMA 3,4-dimethoxyamphetamine
4-MTA 4-methylthioamphetamine
5-HT 5-hydroxytryptamine, serotonin
5-HIAA 5-hydroxyindoleacetic acid
AUC area under the plasma concentration–time curve
BP blood pressure
DOM 4-methyl-2,5-dimethoxyamphetamine
EC effect concentration
GC–MS gas chromatography–mass spectometry
GHB gamma-hydroxybutyric acid
Ki inhibitory constant
LD lethal dose
LSD lysergic acid diethylamide
MA methoxyam pheta mine
MAO monoamineoxidase
MBDB N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine
MDA 3,4-methylenedioxyamphetamine
MDEA 3,4-methylenedioxy-N-ethylamphetamine
MDMA 3,4-methylenedioxy-N-methylamphetamine, ‘ecstasy’
PMA para-methoxyamphetamine
PMMA para-methoxymethamphetamine
p-OH-AMP para-hydroxyamphetamine
< Prev | Next > |
---|